Literature DB >> 27053107

Cleavage by Caspase 8 and Mitochondrial Membrane Association Activate the BH3-only Protein Bid during TRAIL-induced Apoptosis.

Kai Huang1, Jingjing Zhang2, Katelyn L O'Neill1, Channabasavaiah B Gurumurthy3, Rolen M Quadros4, Yaping Tu5, Xu Luo6.   

Abstract

The BH3-only protein Bid is known as a critical mediator of the mitochondrial pathway of apoptosis following death receptor activation. However, since full-length Bid possesses potent apoptotic activity, the role of a caspase-mediated Bid cleavage is not established in vivo In addition, due to the fact that multiple caspases cleave Bid at the same site in vitro, the identity of the Bid-cleaving caspase during death receptor signaling remains uncertain. Moreover, as Bid maintains its overall structure following its cleavage by caspase 8, it remains unclear how Bid is activated upon cleavage. Here, Bid-deficient (Bid KO) colon cancer cells were generated by gene editing, and were reconstituted with wild-type or mutants of Bid. While the loss of Bid blocked apoptosis following treatment by TNF-related apoptosis inducing ligand (TRAIL), this blockade was relieved by re-introduction of the wild-type Bid. In contrast, the caspase-resistant mutant Bid(D60E) and a BH3 defective mutant Bid(G94E) failed to restore TRAIL-induced apoptosis. By generating Bid/Bax/Bak-deficient (TKO) cells, we demonstrated that Bid is primarily cleaved by caspase 8, not by effector caspases, to give rise to truncated Bid (tBid) upon TRAIL treatment. Importantly, despite the presence of an intact BH3 domain, a tBid mutant lacking the mitochondrial targeting helices (α6 and α7) showed diminished apoptotic activity. Together, these results for the first time establish that cleavage by caspase 8 and the subsequent association with the outer mitochondrial membrane are two critical events that activate Bid during death receptor-mediated apoptosis.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  B-cell lymphoma 2 (Bcl-2) family; CRISPR/Cas; apoptosis; mitochondria; transcription activator-like effector nuclease (TALEN)

Mesh:

Substances:

Year:  2016        PMID: 27053107      PMCID: PMC4882451          DOI: 10.1074/jbc.M115.711051

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  BH3-Only proteins-essential initiators of apoptotic cell death.

Authors:  D C Huang; A Strasser
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

2.  Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release.

Authors:  E A Slee; S A Keogh; S J Martin
Journal:  Cell Death Differ       Date:  2000-06       Impact factor: 15.828

3.  Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion.

Authors:  M Chen; H He; S Zhan; S Krajewski; J C Reed; R A Gottlieb
Journal:  J Biol Chem       Date:  2001-06-12       Impact factor: 5.157

Review 4.  Cell death: critical control points.

Authors:  Nika N Danial; Stanley J Korsmeyer
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

5.  Inactivation of caspase-8 on mitochondria of Bcl-xL-expressing MCF7-Fas cells: role for the bifunctional apoptosis regulator protein.

Authors:  Alexander H Stegh; Bryan C Barnhart; Jorg Volkland; Alicia Algeciras-Schimnich; Ning Ke; John C Reed; Marcus E Peter
Journal:  J Biol Chem       Date:  2001-12-03       Impact factor: 5.157

6.  Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route.

Authors:  V Stoka; B Turk; S L Schendel; T H Kim; T Cirman; S J Snipas; L M Ellerby; D Bredesen; H Freeze; M Abrahamson; D Bromme; S Krajewski; J C Reed; X M Yin; V Turk; G S Salvesen
Journal:  J Biol Chem       Date:  2000-11-09       Impact factor: 5.157

7.  Calpain-mediated Bid cleavage and calpain-independent Bak modulation: two separate pathways in cisplatin-induced apoptosis.

Authors:  Aleksandra Mandic; Kristina Viktorsson; Linda Strandberg; Thomas Heiden; Johan Hansson; Stig Linder; Maria C Shoshan
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

8.  BID-D59A is a potent inducer of apoptosis in primary embryonic fibroblasts.

Authors:  Rachel Sarig; Yehudit Zaltsman; Richard C Marcellus; Richard Flavell; Tak W Mak; Atan Gross
Journal:  J Biol Chem       Date:  2003-01-07       Impact factor: 5.157

9.  Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage.

Authors:  J J Reiners; J A Caruso; P Mathieu; B Chelladurai; X-M Yin; D Kessel
Journal:  Cell Death Differ       Date:  2002-09       Impact factor: 15.828

10.  Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins.

Authors:  Tina Cirman; Kristina Oresić; Gabriela Droga Mazovec; Vito Turk; John C Reed; Richard M Myers; Guy S Salvesen; Boris Turk
Journal:  J Biol Chem       Date:  2003-10-27       Impact factor: 5.157

View more
  35 in total

1.  Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparib.

Authors:  Titto Augustine; Radhashree Maitra; Jinghang Zhang; Jay Nayak; Sanjay Goel
Journal:  Invest New Drugs       Date:  2019-01-05       Impact factor: 3.850

2.  Humanin decreases mitochondrial membrane permeability by inhibiting the membrane association and oligomerization of Bax and Bid proteins.

Authors:  Ze-Wei Ma; Dong-Xiang Liu
Journal:  Acta Pharmacol Sin       Date:  2017-12-21       Impact factor: 6.150

3.  Impact of Extracellular pH on Apoptotic and Non-Apoptotic TRAIL-Induced Signaling in Pancreatic Ductal Adenocarcinoma Cells.

Authors:  Sofie Hagelund; Anna Trauzold
Journal:  Front Cell Dev Biol       Date:  2022-02-24

Review 4.  Developing TRAIL/TRAIL death receptor-based cancer therapies.

Authors:  Xun Yuan; Ambikai Gajan; Qian Chu; Hua Xiong; Kongming Wu; Gen Sheng Wu
Journal:  Cancer Metastasis Rev       Date:  2018-12       Impact factor: 9.264

5.  Lipoprotein Particle Formation by Proapoptotic tBid.

Authors:  Vindana Ekanayake; Danielle Nisan; Pavel Ryzhov; Yong Yao; Francesca M Marassi
Journal:  Biophys J       Date:  2018-06-26       Impact factor: 4.033

6.  Death Receptors: New Opportunities in Cancer Therapy.

Authors:  V M Ukrainskaya; A V Stepanov; I S Glagoleva; V D Knorre; A A Jr Belogurov; A G Gabibov
Journal:  Acta Naturae       Date:  2017 Jul-Sep       Impact factor: 1.845

Review 7.  Intracellular localization of DR5 and related regulatory pathways as a mechanism of resistance to TRAIL in cancer.

Authors:  Ufuk Mert; Ahter Dilsad Sanlioglu
Journal:  Cell Mol Life Sci       Date:  2016-08-10       Impact factor: 9.261

8.  BH3-only proteins target BCL-xL/MCL-1, not BAX/BAK, to initiate apoptosis.

Authors:  Kai Huang; Katelyn L O'Neill; Jian Li; Wei Zhou; Na Han; Xiaming Pang; Wei Wu; Lucas Struble; Gloria Borgstahl; Zhaorui Liu; Liqiang Zhang; Xu Luo
Journal:  Cell Res       Date:  2019-09-24       Impact factor: 25.617

Review 9.  Heat shock proteins-driven stress granule dynamics: yet another avenue for cell survival.

Authors:  Akanksha Verma; S Sumi; Mahendra Seervi
Journal:  Apoptosis       Date:  2021-05-12       Impact factor: 4.677

10.  Paclitaxel Impedes EGFR-mutated PC9 Cell Growth via Reactive Oxygen Species-mediated DNA Damage and EGFR/PI3K/AKT/mTOR Signaling Pathway Suppression.

Authors:  Md Mohiuddin; Kazuo Kasahara
Journal:  Cancer Genomics Proteomics       Date:  2021 Sep-Oct       Impact factor: 4.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.